Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility

Journal of Clinical Microbiology

Volumn 47, Issue 12, 2009, Pages 4154-4157

  Kimura, Kouji ^a   Wachino, Jun Ichi ^a   Kurokawa, Hiroshi ^a   Suzuki, Satowa ^a   Yamane, Kunikazu ^a   Shibata, Naohiro ^a   Arakawa, Yoshichika ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ASPOXICILLIN; CEFALEXIN; CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEFBUPERAZONE; CEFEPIME; CEFMENOXIME; CEFMETAZOLE; CEFODIZIME; CEFOPERAZONE; CEFOTAXIME; CEFOTETAN; CEFOTIAM; CEFOXITIN; CEFOZOPRAN; CEFPIRAMIDE; CEFPIROME; CEFSULODIN; CEFTAZIDIME; CEFTIBUTEN; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; OXACILLIN; PENICILLIN G; PIPERACILLIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; FEASIBILITY STUDY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; CEFTIZOXIME; CEPHALOSPORINS; DISK DIFFUSION ANTIMICROBIAL TESTS; HUMANS; OXACILLIN; PENICILLIN RESISTANCE; PENICILLINS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS SP. 'GROUP B';

EID: 71549167993     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02063-08     Document Type: Article

References (12)

1. Baker, C. J. 2000. Group B streptococcal infections. p. 222-237. In D. L. Stevens and E. L. Kaplan (ed.), Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, Oxford, England.
2. Centers for Disease Control and Prevention. 2002. Prevention of perinatal group B streptococcal disease. MMWR Morb. Mortal. Wkly. Rep. 51:1-22.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Dahesh, S., M. E. Hensler, N. M. Van Sorge, R. E. Gertz, Jr., S. Schrag, V. Nizet, and B. W. Beall. 2008. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob. Agents Chemother. 52:2915-2918.
5. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811.
6. Heath, P. T., G. Balfour, A. M. Weisner, A. Efstratiou, T. L. Lamagni, H. Tighe, L. A. O'Connell, M. Cafferkey, N. Q. Verlander, A. Nicoll, A. C. McCartney, and the PHLS Group B Streptococcus Working Group. 2004. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363:292-294.
7. Jackson, L. A., R. Hilsdon, M. M. Farley, L. H. Harrison, A. L. Reingold, B. D. Plikaytis, J. D. Wenger, and A. Schuchat. 1995. Risk factors for group B streptococcal disease in adults. Ann. Intern. Med. 123:415-420.
8. Johri, A. K., L. C. Paoletti, P. Glaser, M. Dua, P. K. Sharma, G. Grandi, and R. Rappuoli. 2006. Group B streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4:932-942.
9. Kimura, K., S. Suzuki, J. Wachino, H. Kurokawa, K. Yamane, N. Shibata, N. Nagano, H. Kato, K. Shibayama, and Y. Arakawa. 2008. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob. Agents Chemother. 52:2890-2897.
10. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
11. Schuchat, A. 1999. Group B streptococcus. Lancet 353:51-56.
12. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347:240-247.